Indian herb cuts insulin, blood sugar levels
A herbal used in traditional Indian medicine to treat diabetes seems to lower blood sugar and insulin levels in the same way as prescription drugs.
Archives for February 14, 2005
Nutra businesses sought after as M&A surges
Strong demand for thriving health foods and supplements businesses is putting sellers in a strong negotiating position, according to a report that is due to be published this month by investment bank Health Business Partners (HBP).
Forward cover offers comfort to soybean stocks
Global stocks of soybeans continue to rise after last year's price spiking draw-down, with oilseed production for 2004-05 projected to reach 390.2 million tonnes, providing a 'comfort-zone' for inventory levels.
Nutrition 21 maintains turnaround in "significant quarter"
The maker of chromium-based supplements has reported a 12.6 percent sales increase for the quarter ended 31 December 2004, up to $2.6 million compared with $2.3 million for the same period of last year.
FDA delays again on lycopene/cancer decision
The FDA has requested a second extension on giving a decision on American Longevity's health claim petition on the link between lycopene and a reduced risk of developing certain types of cancer, until 12 April.
New company on the look-out for supplement acquisitions
A new company founded by several high profile executives in the UK will start trading shares this week to fund acquisitions in the nutraceuticals sector.
Herbalife halts sale of digestion product in Israel
Leading supplements distributor Herbalife said yesterday that it had stopped selling one of its products in Israel after an investigation by health officials over complaints that it caused liver problems.
Industry nutrition labels clash with government plans
The British arm of Nestlé has become the latest food producer to revamp its nutrition labels, yet the country's food industry is on rocky ground by entrenching its support for guideline daily amounts against the government's wishes, argues Chris Mercer.